Ipsen Zukünftiges Wachstum
Future Kriterienprüfungen 1/6
Ipsen wird ein jährliches Gewinn- und Umsatzwachstum von 7% bzw. 5.5% prognostiziert. Der Gewinn pro Aktie wird voraussichtlich wachsen um 6.9% pro Jahr. Die Eigenkapitalrendite wird in 3 Jahren voraussichtlich 14.8% betragen.
Wichtige Informationen
7.0%
Wachstumsrate der Gewinne
6.9%
EPS-Wachstumsrate
Pharmaceuticals Gewinnwachstum | 17.1% |
Wachstumsrate der Einnahmen | 5.5% |
Zukünftige Eigenkapitalrendite | 14.8% |
Analystenabdeckung | Good |
Zuletzt aktualisiert | 04 Nov 2024 |
Jüngste Aktualisierungen zum künftigen Wachstum
Recent updates
What Ipsen S.A.'s (EPA:IPN) P/E Is Not Telling You
Sep 30These 4 Measures Indicate That Ipsen (EPA:IPN) Is Using Debt Reasonably Well
Sep 08An Intrinsic Calculation For Ipsen S.A. (EPA:IPN) Suggests It's 42% Undervalued
Jun 16Ipsen (EPA:IPN) Has Announced A Dividend Of €1.20
May 29We Think Shareholders May Consider Being More Generous With Ipsen S.A.'s (EPA:IPN) CEO Compensation Package
May 22Ipsen (EPA:IPN) Has Affirmed Its Dividend Of €1.20
May 08Ipsen (EPA:IPN) Has Affirmed Its Dividend Of €1.20
Apr 20There's Reason For Concern Over Ipsen S.A.'s (EPA:IPN) Price
Apr 13Ipsen (EPA:IPN) Seems To Use Debt Quite Sensibly
Mar 26Investors Still Waiting For A Pull Back In Ipsen S.A. (EPA:IPN)
Dec 30These 4 Measures Indicate That Ipsen (EPA:IPN) Is Using Debt Reasonably Well
Dec 11Are Investors Undervaluing Ipsen S.A. (EPA:IPN) By 31%?
Sep 28These 4 Measures Indicate That Ipsen (EPA:IPN) Is Using Debt Reasonably Well
Sep 07Is There An Opportunity With Ipsen S.A.'s (EPA:IPN) 34% Undervaluation?
Jun 21Ipsen (EPA:IPN) Is Due To Pay A Dividend Of €1.20
Jun 02Ipsen's (EPA:IPN) Dividend Will Be €1.20
May 12Ipsen S.A. (EPA:IPN) Shares Could Be 48% Below Their Intrinsic Value Estimate
Mar 19Ipsen (EPA:IPN) Has A Pretty Healthy Balance Sheet
Mar 01Ipsen (EPA:IPN) Ticks All The Boxes When It Comes To Earnings Growth
Jan 19Is There An Opportunity With Ipsen S.A.'s (EPA:IPN) 46% Undervaluation?
Dec 08We Think Ipsen (EPA:IPN) Can Manage Its Debt With Ease
Nov 02Does Ipsen (EPA:IPN) Deserve A Spot On Your Watchlist?
Oct 14Does Ipsen (EPA:IPN) Have A Healthy Balance Sheet?
Aug 01Here's Why We Think Ipsen (EPA:IPN) Might Deserve Your Attention Today
Jul 10Ipsen (EPA:IPN) Will Pay A Larger Dividend Than Last Year At €1.20
May 26Gewinn- und Umsatzwachstumsprognosen
Datum | Umsatz | Gewinne | Freier Cashflow | Bargeld aus operativen Tätigkeiten | Durchschn. Anz. Analysten |
---|---|---|---|---|---|
12/31/2026 | 3,932 | 802 | 848 | 1,109 | 11 |
12/31/2025 | 3,686 | 730 | 794 | 1,020 | 12 |
12/31/2024 | 3,490 | 627 | 630 | 849 | 13 |
6/30/2024 | 3,435 | 664 | 425 | 903 | N/A |
3/31/2024 | 3,371 | 641 | 554 | 884 | N/A |
12/31/2023 | 3,306 | 617 | 683 | 866 | N/A |
6/30/2023 | 3,282 | 406 | 764 | 972 | N/A |
3/31/2023 | 3,219 | 500 | 741 | 971 | N/A |
12/31/2022 | 3,156 | 593 | 719 | 971 | N/A |
9/30/2022 | 3,053 | 656 | 615 | 972 | N/A |
6/30/2022 | 2,950 | 719 | 512 | 973 | N/A |
3/31/2022 | 2,849 | 675 | 494 | 933 | N/A |
12/31/2021 | 2,749 | 631 | 475 | 893 | N/A |
9/30/2021 | 2,712 | 626 | 570 | 860 | N/A |
6/30/2021 | 2,676 | 622 | 665 | 827 | N/A |
3/31/2021 | 2,681 | 585 | 649 | 799 | N/A |
12/31/2020 | 2,686 | 548 | 632 | 771 | N/A |
9/30/2020 | 2,697 | 249 | 564 | 750 | N/A |
6/30/2020 | 2,707 | -50 | 496 | 729 | N/A |
3/31/2020 | 2,700 | -53 | 421 | 678 | N/A |
12/31/2019 | 2,693 | -55 | 347 | 628 | N/A |
9/30/2019 | 2,605 | 176 | 310 | 591 | N/A |
6/30/2019 | 2,516 | 406 | 272 | 555 | N/A |
3/31/2019 | 2,432 | 397 | 279 | 563 | N/A |
12/31/2018 | 2,348 | 388 | 285 | 571 | N/A |
9/30/2018 | 2,258 | 365 | N/A | N/A | N/A |
6/30/2018 | 2,167 | 343 | 280 | 502 | N/A |
3/31/2018 | 2,090 | 307 | N/A | 463 | N/A |
12/31/2017 | 2,012 | 270 | N/A | 423 | N/A |
9/30/2017 | 1,923 | 243 | N/A | N/A | N/A |
6/30/2017 | 1,834 | 217 | N/A | 316 | N/A |
3/31/2017 | 1,753 | 221 | N/A | 317 | N/A |
12/31/2016 | 1,671 | 226 | N/A | 318 | N/A |
9/30/2016 | 1,623 | 229 | N/A | N/A | N/A |
6/30/2016 | 1,575 | 233 | N/A | 318 | N/A |
3/31/2016 | 1,548 | 211 | N/A | 271 | N/A |
12/31/2015 | 1,520 | 189 | N/A | 224 | N/A |
9/30/2015 | 1,468 | 165 | N/A | 225 | N/A |
6/30/2015 | 1,416 | 140 | N/A | 227 | N/A |
3/31/2015 | 1,374 | 147 | N/A | 237 | N/A |
12/31/2014 | 1,332 | 154 | N/A | 246 | N/A |
9/30/2014 | 1,310 | 155 | N/A | 217 | N/A |
6/30/2014 | 1,287 | 156 | N/A | 188 | N/A |
3/31/2014 | 1,284 | 149 | N/A | 188 | N/A |
12/31/2013 | 1,282 | 142 | N/A | 188 | N/A |
Analystenprognosen zum zukünftigen Wachstum
Einkommen vs. Sparrate: IPNDas prognostizierte Gewinnwachstum (7% pro Jahr) liegt über der Sparquote (1.4%).
Ertrag vs. Markt: IPNDie Erträge des Unternehmens (7% pro Jahr) werden voraussichtlich langsamer wachsen als der Markt French (12.5% pro Jahr).
Hohe Wachstumserträge: IPNDie Erträge des Unternehmens werden voraussichtlich steigen, jedoch nicht deutlich.
Einnahmen vs. Markt: IPNDie Einnahmen des Unternehmens (5.5% pro Jahr) werden voraussichtlich langsamer wachsen als der Markt French (5.6% pro Jahr).
Hohe Wachstumseinnahmen: IPNDie Einnahmen des Unternehmens (5.5% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.
Wachstumsprognosen für den Gewinn je Aktie
Künftige Eigenkapitalrendite
Künftige Eigenkapitalrendite: IPNDie Eigenkapitalrendite des Unternehmens wird in 3 Jahren voraussichtlich niedrig sein (14.8%).